342 related articles for article (PubMed ID: 18821708)
21. Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models.
Yang S; Eaton CB; McAlindon TE; Lapane KL
Arthritis Rheumatol; 2015 Mar; 67(3):714-23. PubMed ID: 25369761
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.
Reginster JY; Deroisy R; Rovati LC; Lee RL; Lejeune E; Bruyere O; Giacovelli G; Henrotin Y; Dacre JE; Gossett C
Lancet; 2001 Jan; 357(9252):251-6. PubMed ID: 11214126
[TBL] [Abstract][Full Text] [Related]
23. A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis.
Vangsness CT; Spiker W; Erickson J
Arthroscopy; 2009 Jan; 25(1):86-94. PubMed ID: 19111223
[TBL] [Abstract][Full Text] [Related]
24. Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials.
Simental-Mendía M; Sánchez-García A; Vilchez-Cavazos F; Acosta-Olivo CA; Peña-Martínez VM; Simental-Mendía LE
Rheumatol Int; 2018 Aug; 38(8):1413-1428. PubMed ID: 29947998
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis.
Das A; Hammad TA
Osteoarthritis Cartilage; 2000 Sep; 8(5):343-50. PubMed ID: 10966840
[TBL] [Abstract][Full Text] [Related]
26. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial.
Michel BA; Stucki G; Frey D; De Vathaire F; Vignon E; Bruehlmann P; Uebelhart D
Arthritis Rheum; 2005 Mar; 52(3):779-86. PubMed ID: 15751094
[TBL] [Abstract][Full Text] [Related]
27. Quantitative microfocal radiography detects changes in OA knee joint space width in patients in placebo controlled trial of NSAID therapy.
Buckland-Wright JC; MacFarlane DG; Lynch JA; Jasani MK
J Rheumatol; 1995 May; 22(5):937-43. PubMed ID: 8587086
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT).
Reginster JY; Dudler J; Blicharski T; Pavelka K
Ann Rheum Dis; 2017 Sep; 76(9):1537-1543. PubMed ID: 28533290
[TBL] [Abstract][Full Text] [Related]
29. Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: Data from the OAI progression cohort.
Roubille C; Martel-Pelletier J; Abram F; Dorais M; Delorme P; Raynauld JP; Pelletier JP
Semin Arthritis Rheum; 2015 Dec; 45(3):257-67. PubMed ID: 26094904
[TBL] [Abstract][Full Text] [Related]
30. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation.
Black C; Clar C; Henderson R; MacEachern C; McNamee P; Quayyum Z; Royle P; Thomas S
Health Technol Assess; 2009 Nov; 13(52):1-148. PubMed ID: 19903416
[TBL] [Abstract][Full Text] [Related]
31. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate.
Deal CL; Moskowitz RW
Rheum Dis Clin North Am; 1999 May; 25(2):379-95. PubMed ID: 10356424
[TBL] [Abstract][Full Text] [Related]
32. Glucosamine and Chondroitin Sulfate: What Has Been Learned Since the Glucosamine/chondroitin Arthritis Intervention Trial.
DiNubile N
Orthopedics; 2018 Jul; 41(4):200-207. PubMed ID: 29771395
[TBL] [Abstract][Full Text] [Related]
33. Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis.
Lomonte ABV; Mendonça JA; de Castro Brandão G; Castro ML
Adv Rheumatol; 2018 Dec; 58(1):41. PubMed ID: 30657100
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Rondanelli M; Braschi V; Gasparri C; Nichetti M; Faliva MA; Peroni G; Naso M; Iannello G; Spadaccini D; Miraglia N; Putignano P; Alalwan TA; Perna S
Nutrients; 2019 Aug; 11(9):. PubMed ID: 31470599
[TBL] [Abstract][Full Text] [Related]
35. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?
Henrotin Y; Marty M; Mobasheri A
Maturitas; 2014 Jul; 78(3):184-7. PubMed ID: 24861964
[TBL] [Abstract][Full Text] [Related]
36. Reproducibility of the semiflexed (metatarsophalangeal) radiographic knee position and automated measurements of medial tibiofemoral joint space width in a multicenter clinical trial of knee osteoarthritis.
Buckland-Wright JC; Ward RJ; Peterfy C; Mojcik CF; Leff RL
J Rheumatol; 2004 Aug; 31(8):1588-97. PubMed ID: 15290740
[TBL] [Abstract][Full Text] [Related]
37. Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.
Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Clauw D; Jones M; Bergfeld J; Swearingen CJ; DiFrancesco A; Simsek I; Tambiah J; Hochberg MC
Arthritis Rheumatol; 2020 Oct; 72(10):1694-1706. PubMed ID: 32432388
[TBL] [Abstract][Full Text] [Related]
38. Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial.
Rozendaal RM; Uitterlinden EJ; van Osch GJ; Garling EH; Willemsen SP; Ginai AZ; Verhaar JA; Weinans H; Koes BW; Bierma-Zeinstra SM
Osteoarthritis Cartilage; 2009 Apr; 17(4):427-32. PubMed ID: 18848470
[TBL] [Abstract][Full Text] [Related]
39. Comparison of conventional standing knee radiographs and magnetic resonance imaging in assessing progression of tibiofemoral joint osteoarthritis.
Cicuttini F; Hankin J; Jones G; Wluka A
Osteoarthritis Cartilage; 2005 Aug; 13(8):722-7. PubMed ID: 15922634
[TBL] [Abstract][Full Text] [Related]
40. OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.
Karsdal MA; Bihlet A; Byrjalsen I; Alexandersen P; Ladel C; Michaels M; Andersen JR; Riis BJ; Kraus V; Bay-Jensen AC; Christiansen C
Osteoarthritis Cartilage; 2015 Apr; 23(4):550-8. PubMed ID: 25576879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
